Article Versions Notes

Juhász Á, Surguta SE, Svajda L, Ranđelović I, Ladányi A, Tóvári J, Cserepes M. Importance of Patient-Derived Xenograft Models in Battling Cancer Therapy Resistance. Cancers. 2026; 18(14):2187. https://doi.org/10.3390/cancers18142187

Juhász, Ákos, Sára Eszter Surguta, Laura Svajda, Ivan Ranđelović, Andrea Ladányi, József Tóvári, and Mihály Cserepes. 2026. "Importance of Patient-Derived Xenograft Models in Battling Cancer Therapy Resistance" Cancers 18, no. 14: 2187. https://doi.org/10.3390/cancers18142187

Juhász, Á., Surguta, S. E., Svajda, L., Ranđelović, I., Ladányi, A., Tóvári, J., & Cserepes, M. (2026). Importance of Patient-Derived Xenograft Models in Battling Cancer Therapy Resistance. Cancers, 18(14), 2187. https://doi.org/10.3390/cancers18142187